These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31019163)

  • 1. Implication of Preoperative Existence of Atrial Fibrillation on Hemocompatibility-Related Adverse Events During Left Ventricular Assist Device Support.
    Imamura T; Kinugawa K; Ono M; Kinoshita O; Fukushima N; Shiose A; Matsui Y; Yamazaki K; Saiki Y; Usui A; Niinami H; Matsumiya G; Arai H; Sawa Y
    Circ J; 2019 May; 83(6):1286-1292. PubMed ID: 31019163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States.
    Imamura T; Ono M; Kinugawa K; Fukushima N; Shiose A; Matsui Y; Yamazaki K; Saiki Y; Usui A; Niinami H; Matsumiya G; Arai H; Sawa Y; Uriel N
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32183082
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.
    Stulak JM; Deo S; Schirger J; Aaronson KD; Park SJ; Joyce LD; Daly RC; Pagani FD
    Ann Thorac Surg; 2013 Dec; 96(6):2161-7. PubMed ID: 24035302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and adverse events in patients with atrial fibrillation at left ventricular assist device implantation: an analysis of the European Registry for Patients with Mechanical Circulatory Support.
    Antonides CFJ; Yalcin YC; Veen KM; Muslem R; De By TMMH; Bogers AJJC; Gustafsson F; Caliskan K
    Eur J Cardiothorac Surg; 2022 May; 61(5):1164-1175. PubMed ID: 35076057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device.
    Enriquez AD; Calenda B; Gandhi PU; Nair AP; Anyanwu AC; Pinney SP
    J Am Coll Cardiol; 2014 Nov; 64(18):1883-90. PubMed ID: 25444141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy.
    Pedde D; Soltani S; Stein J; Tsyganenko D; Müller M; Schönrath F; Falk V; Potapov EV
    Eur J Cardiothorac Surg; 2020 Feb; 57(2):325-330. PubMed ID: 31317177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Atrial Fibrillation on In-Hospital Mortality and Thromboembolic Complications after Left Ventricular Assist Device Implantation.
    Blumer V; Ortiz Bezara M; Kittipibul V; Greene SJ; Fudim M; Hernandez GA; Chaparro S; Joyce E
    J Cardiovasc Transl Res; 2021 Feb; 14(1):120-124. PubMed ID: 32076994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative atrial fibrillation may not increase thromboembolic events in left ventricular assist device recipients on midterm follow-up.
    Xia Y; Stern D; Friedmann P; Goldstein D
    J Heart Lung Transplant; 2016 Jul; 35(7):906-12. PubMed ID: 27132796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Preoperative Atrial Fibrillation on Postoperative Thromboembolic Events After Left Ventricular Assist Device Implantation.
    Xuereb L; Go PH; Kaur B; Akrawe S; Nemeh HW; Borgi J; Williams CT; Paone G; Morgan JA
    Ann Thorac Surg; 2016 Nov; 102(5):1543-1549. PubMed ID: 27469338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events.
    Imamura T; Nguyen A; Kim G; Raikhelkar J; Sarswat N; Kalantari S; Smith B; Juricek C; Rodgers D; Ota T; Song T; Jeevanandam V; Sayer G; Uriel N
    Eur J Heart Fail; 2019 May; 21(5):655-662. PubMed ID: 30592363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permanent Atrial Fibrillation and 2 Year Clinical Outcomes in Patients with a Left Ventricular Assist Device Implant.
    Oezpeker C; Zittermann A; Pühler T; Ensminger S; Gummert JF; Morshuis M
    ASAIO J; 2017; 63(4):419-424. PubMed ID: 28118262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 and hemocompatibility-related adverse events.
    Imamura T; Nguyen A; Rodgers D; Kim G; Raikhelkar J; Kalantari S; Narang N; Juricek C; Ota T; Jeevanandam V; Sayer G; Uriel N
    J Card Surg; 2020 Feb; 35(2):405-412. PubMed ID: 31850548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of ventricular arrhythmia after left ventricular assist device implantation: A large single-center observational study.
    Efimova E; Fischer J; Bertagnolli L; Dinov B; Kircher S; Rolf S; Sommer P; Bollmann A; Richter S; Meyer A; Garbade J; Hindricks G; Arya A
    Heart Rhythm; 2017 Dec; 14(12):1812-1819. PubMed ID: 28756099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device.
    Yoruk A; Sherazi S; Massey HT; Kutyifa V; McNitt S; Hallinan W; Huang DT; Chen L; Aktas MK
    Heart Rhythm; 2016 May; 13(5):1052-1056. PubMed ID: 26829113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of functional mitral regurgitation and atrial fibrillation in patients with left ventricular assist devices.
    Hayashi H; Naka Y; Sanchez J; Takayama H; Kurlansky P; Ning Y; Topkara VK; Yuzefpolskaya M; Colombo PC; Sayer GT; Uriel N; Takeda K
    J Heart Lung Transplant; 2020 Dec; 39(12):1398-1407. PubMed ID: 32994093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.